Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.001 Å; R factor = 0.042; wR factor = 0.117; data-to-parameter ratio = 23.7.
In the title compound, C 10 H 16 N 2 OÁH 2 O, the cyclohexane ring is in a chair conformation and its least-squares plane makes a dihedral angle of 53.68 (5) with the approximately planar pyrazole ring [maximum deviation = 0.034 (1) Å ]. Pairs of intermolecular N-HÁ Á ÁO hydrogen bonds form inversion dimers between neighbouring pyrazolone molecules, generating R 2 2 (8) ring motifs. The pyrazolone and water molecules are further linked by intermolecular N-HÁ Á ÁO, C-HÁ Á ÁO and O-HÁ Á ÁO hydrogen bonds into two-dimensional sheets parallel to the bc plane.
Related literature
For pyrazole derivatives and their microbial activities, see: Ragavan et al. (2009 Ragavan et al. ( , 2010 . For related structures, see: Shahani et al. (2009 Shahani et al. ( , 2010a . For ring conformations, see : Cremer & Pople (1975) . For hydrogen-bond motifs, see: Bernstein et al. (1995) . For bond-length data, see: Allen et al. (1987) . For the stability of the temperature controller used for the data collection, see : Cosier & Glazer (1986 Table 1 Hydrogen-bond geometry (Å , ). 
Data collection: APEX2 (Bruker, 2009 ); cell refinement: SAINT (Bruker, 2009) as anti-microbial agents. However, the existence of azole-resistant strains had led to the development of new antimicrobial compounds. In particular, pyrazole derivatives are also extensively studied and used as antimicrobial agents. Pyrazole is an important class of heterocyclic compound and many pyrazole derivatives are reported to have the broad spectrum of biological activities, such as anti-inflammatory, antifungal, herbicidal, anti-tumour, cytotoxic and antiviral activities. Pyrazole derivatives also act as antiangiogenic agents, A3 adenosine receptor antagonists, neuropeptide YY5 receptor antagonists, kinase inhibitor for treatment of type-2 diabetes, hyperlipidemia, obesity, and thrombopiotinmimetics. Recently urea derivatives of pyrazoles have been reported as potent inhibitors of p38 kinase. Since the high electronegativity of halogens (particularly chlorine and fluorine) in the aromatic part of the drug molecules play an important role in enhancing their biological activity, we are interested to have 4-fluoro or 4-chloro substitution in the aryls of 1,5-diaryl pyrazoles. As part of our on-going research aiming on the synthesis of new antimicrobial compounds, we have reported the synthesis of novel pyrazole derivatives and their microbial activities (Ragavan et al., , 2010 .
The asymmetric unit of the title compound, (Fig. 1) , consists of one 5-cyclohexyl-4-methyl-1H-pyrazol-3(2H)-one molecule (C1-C10/N1/N2/O1) and one water molecule. The 3-cyclohexyl-4-methyl-1 H-pyrazol-5-ol undergoes an enol-toketo tautomerism during the crystallization process (Fig. 2) . The cyclohexane ring is in a chair conformation with puckering parameters of Q = 0.5813 (10) Å, Θ = 177.06 (10)° and φ = 164.9 (19)° (Cremer & Pople, 1975) , and its least-squares plane is at an angle of 53.68 (5)° with the approximately planar pyrazole ring (C7-C9/N1/N2; maximum deviation of 0.034 (1) Å at atom N2). The bond lengths (Allen et al., 1987) and angles are within normal ranges and comparable to those closely related structures (Shahani et al., 2009 (Shahani et al., , 2010a In the crystal packing (Fig. 3) , pairs of intermolecular N2-H1N2···O1 hydrogen bonds (Table 1) form dimers with neighbouring molecules, generating R 2 2 (8) ring motifs (Bernstein et al., 1995) . The molecules are further linked by intermolecular N1-H1N1···O1W, C5-H5A···O1W, O1W-H1W1···O1 and O1W-H1W2 ···O1 hydrogen bonds (Table 1) into two-dimensional sheets parallel to the bc plane.
Experimental
The compound has been synthesized using the method available in the literature (Ragavan et al., 2010) supplementary materials sup-2 Figures   Fig. 1 . The molecular structure of the title compound, showing 50% probability displacement ellipsoids and the atom numbering scheme. Fig. 2 . Enol-to-keto tautomerism of the title compound during crystallization process. Fig. 3 . The crystal packing of the title compound, viewed two-dimensional arrays parallel to the bc plane. Dashed lines indicate hydrogen bonds. 
5-Cyclohexyl-4-methyl-1H-pyrazol-3(2H)-one monohydrate

Crystal data
Special details
Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986 ) operating at 100.0 (1) K. 
